CA
HAE icon

CWC Advisors’s Haemonetics HAE Stock Holding History

CWC Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$292K Sell
3,888
-217
-5% -$13.9K 0.13% 129
2026
Q1 		$231K Sell
4,105
-439
-10% -$28.6K 0.11% 137
2025
Q4 		$364K Sell
4,544
-7
-0.2% -$470 0.18% 116
2025
Q3 		$222K Buy
4,551
+328
+8% +$20.3K 0.11% 137
2025
Q2 		$315K Buy
4,223
+105
+3% +$6.95K 0.16% 116
2025
Q1 		$262K Buy
4,118
+1,035
+34% +$70.4K 0.15% 123
2024
Q4 		$241K Buy
3,083
+212
+7% +$17K 0.24% 105
2024
Q3 		$231K Buy
+2,871
New +$232K 0.23% 108

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CWC Advisors's HAE Position: Q2 2026 in Review

CWC Advisors reduced its Haemonetics (HAE) stake by 5.3% in Q2 2026, selling an estimated $13.9K and leaving 3,888 shares worth $292K. The position accounts for 0.13% of the portfolio, ranked #129.

CWC Advisors first reported a position in HAE in Q3 2024 and has held it in 8 quarters since. The position peaked at $364K in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • CWC Advisors held 3,888 shares of Haemonetics worth $292K as of Q2 2026.
  • CWC Advisors sold 217 Haemonetics shares in Q2 2026, an estimated $13.9K.
  • Haemonetics made up 0.13% of CWC Advisors's portfolio in Q2 2026, its #129 holding.
  • CWC Advisors first reported a position in Haemonetics in Q3 2024 and has held it in 8 quarters since.
  • CWC Advisors's Haemonetics position peaked at $364K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on CWC Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.